Covered recipient · General Payments record
KADY M VEGA
Physician Assistants & Advanced Practice Nursing Providers Nurse Practitioner Family
General Payments · PY2021–2024
$1,685.64
- Reported across 106 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $361.02 | 27 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Lilly USA, LLC | $180.43 | 17 |
| Amgen Inc. | $38.49 | 2 |
| Astellas Pharma US Inc | $33.80 | 2 |
| Novo Nordisk AS | $31.01 | 2 |
| Janssen Pharmaceuticals, Inc | $21.59 | 1 |
| GlaxoSmithKline, LLC. | $20.31 | 1 |
| ABBVIE INC. | $20.14 | 1 |
| Exact Sciences Corporation | $15.25 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (27)
Sorted by paying entity, then date · as published by CMS
Program year 2024 202120222023
Record-level detail is published for PY2024; earlier years are summarised in
“By program year”.
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $20.14 | 10/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108353868 | CMS |
| Amgen Inc. | $18.45 | 01/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117406038 | CMS |
| Amgen Inc. | $20.04 | 02/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117708652 | CMS |
| Astellas Pharma US Inc | $13.58 | 01/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139488906 | CMS |
| Astellas Pharma US Inc | $20.22 | 03/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139478214 | CMS |
| Exact Sciences Corporation | $15.25 | 09/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1114524752 | CMS |
| GlaxoSmithKline, LLC. | $20.31 | 09/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116456947 | CMS |
| Janssen Pharmaceuticals, Inc | $21.59 | 02/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1078202593 | CMS |
| Lilly USA, LLC | $13.90 | 02/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135705160 | CMS |
| Lilly USA, LLC | $10.08 | 03/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135705162 | CMS |
| Lilly USA, LLC | $1.31 | 03/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135723667 | CMS |
| Lilly USA, LLC | $18.09 | 05/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135723669 | CMS |
| Lilly USA, LLC | $3.91 | 07/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135730336 | CMS |
| Lilly USA, LLC | $13.05 | 08/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135723665 | CMS |
| Lilly USA, LLC | $17.48 | 09/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135719580 | CMS |
| Lilly USA, LLC | $16.78 | 09/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135723673 | CMS |
| Lilly USA, LLC | $13.53 | 09/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135723671 | CMS |
| Lilly USA, LLC | $5.39 | 09/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135730338 | CMS |
| Lilly USA, LLC | $2.08 | 10/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135663385 | CMS |
| Lilly USA, LLC | $9.07 | 10/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135723675 | CMS |
| Lilly USA, LLC | $8.12 | 10/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135732032 | CMS |
| Lilly USA, LLC | $3.66 | 11/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135721823 | CMS |
| Lilly USA, LLC | $14.79 | 11/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135721825 | CMS |
| Lilly USA, LLC | $9.82 | 11/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135719582 | CMS |
| Lilly USA, LLC | $19.37 | 11/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135721827 | CMS |
| Novo Nordisk Inc | $16.34 | 08/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100341008 | CMS |
| Novo Nordisk Inc | $14.67 | 11/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100454318 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2021, 2022, 2023, 2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.